Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Jounce Therapeutics, Inc. | 4,447,829 | reported | 10 Jun 2021 | tx 6+12,737,124−49,950,000 |
| Fulcrum Therapeutics, Inc. | 3,962,202 | reported | 10 Nov 2021 | tx 6+5,676,488−41,166,667 |
| CytomX Therapeutics, Inc. | 3,320,348 | reported | 18 Oct 2017 | tx 2−1,028,357 |
| CONSTELLATION PHARMACEUTICALS INC | 3,034,083 | reported | 22 Aug 2018 | tx 2+51,032−51,032 |
| MyoKardia Inc | 885,104 | reported | 07 Mar 2018 | tx 17+10,362,135−47,394,289 |
| Larimar Therapeutics, Inc. | 272,001 | reported | 24 Sept 2015 | tx 26+7,723,352−42,318,361 |
| Global Blood Therapeutics, Inc. | 82,544 | reported | 16 Dec 2016 | tx 6+14,204,476−49,772,123 |
| ALNYLAM PHARMACEUTICALS, INC. | 11,250 | reported | 02 Jun 2017 | tx 56+475,051−435,262 |
| Sage Therapeutics, Inc. | 10,000 | reported | 15 Jun 2023 | tx 45+11,837,931−47,446,091 |
| HUMAN GENOME SCIENCES INC | 695.21 | reported | 10 Jul 2007 | tx 3+41,695.21 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 9,947 | 0.00 USD | deriv |
| 10 Nov 2021 | OTHER | Fulcrum Therapeutics, Inc. | 1,000,000 | — | |
| 22 Sept 2021 | OTHER | Fulcrum Therapeutics, Inc. | 1,000,000 | — | |
| 16 Jun 2021 | PURCHASE | Sage Therapeutics, Inc. | 17,842 | 56.05 USD | first after silence |
| 10 Jun 2021 | OTHER | Jounce Therapeutics, Inc. | 1,500,000 | — | |
| 10 Jun 2021 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 01 Mar 2021 | SALE | Jounce Therapeutics, Inc. | 1,450,000 | 11.75 USD | |
| 09 Jun 2020 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 22 Jul 2019 | PURCHASE | Fulcrum Therapeutics, Inc. | 81,250 | 16.00 USD | |
| 22 Jul 2019 | CONVERSION | Fulcrum Therapeutics, Inc. | 5,595,238 | — | |
| 22 Jul 2019 | CONVERSION | Fulcrum Therapeutics, Inc. | 0 | 0.00 USD | deriv |
| 22 Jul 2019 | CONVERSION | Fulcrum Therapeutics, Inc. | 39,166,667 | 0.00 USD | deriv |
| 05 Jun 2019 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 12 Feb 2019 | SALE | Sage Therapeutics, Inc. | 0 | 0.00 USD | |
| 22 Aug 2018 | EXERCISE | CONSTELLATION PHARMACEUTICALS INC | 51,032 | 1.55 USD | |
| 22 Aug 2018 | EXERCISE | CONSTELLATION PHARMACEUTICALS INC | 51,032 | 0.00 USD | deriv |
| 06 Jun 2018 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 17 Apr 2018 | SALE | Sage Therapeutics, Inc. | 35,000 | 169.25 USD | |
| 18 Apr 2018 | SALE | Sage Therapeutics, Inc. | 24,000 | 168.28 USD | |
| 07 Mar 2018 | OTHER | MyoKardia Inc | 2,000,000 | — | |
| 16 Feb 2018 | OTHER | Sage Therapeutics, Inc. | 510,554 | — | |
| 03 Jan 2018 | SALE | MyoKardia Inc | 816,326 | 42.00 USD | |
| 06 Dec 2017 | OTHER | MyoKardia Inc | 2,000,000 | — | |
| 18 Oct 2017 | OTHER | CytomX Therapeutics, Inc. | 1,000,000 | — |
1 purchase reported after at least 12 months of silence — most recent on 16 Jun 2021.